This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sendid, B. Articles by Poulain, D. Search for Related Content PubMed PubMed Citation Articles by Sendid, B. Articles by Poulain, D.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 03 1996, 219-226, Vol 3, No. 2
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Specific antibody response to oligomannosidic epitopes in Crohn's disease

B Sendid, JF Colombel, PM Jacquinot, C Faille, J Fruit, A Cortot, D Lucidarme, D Camus and D Poulain
Laboratoire de Parasitologie-Mycologie, Hopital Huriez, CHRU de Lille, France.

Elevated antibody levels against the yeast Saccharomyces cerevisiae have been reported in sera from patients with Crohn's disease and not with ulcerative colitis. The aim of the study was to identify the nature of the epitopes supporting this antibody response. Whole cells from different S. cerevisiae strains were selected in immunofluorescence assay for their ability to differentiate the antibody responses of patients with Crohn's disease and ulcerative colitis. Their cell wall phosphopeptidomannans were then tested as antigen in enzyme-linked immunosorbent assay (ELISA) against sera from 42 patients with Crohn's disease, 20 patients with ulcerative colitis, and 34 healthy controls. Graded chemical degradations were performed on the most reactive strain phosphopeptidomannan. The discriminating epitope was determined through gas-liquid chromatography-mass spectrometry. The greatest discrimination among patients with Crohn's disease, ulcerative colitis, and controls was obtained with Su1, a S. cerevisiae strain used in brewing of beer. ELISA directed against phosphopeptidomannan of this strain was 64% sensitive and 77% specific for discriminating Crohn's disease versus ulcerative colitis and 71% sensitive and 89% specific for Crohn's disease versus controls. Periodate oxidation and selective degradation demonstrated that the most important polysaccharide epitope was shared by both the acid- stable and the alkali-labile domains of the phosphopeptidomannan. The determination of oligomannose sequences of S. cerevisiae Su1 phosphopeptidomannans suggested that a mannotetraose, Man (1 --> 3)Man(1 --> 2)Man(1 --> 2)Man, supported the serological response seen in Crohn's disease. Further identification of the immunogen eliciting this antibody response as a marker of the disease may help to understand its etiology.

This article has been cited by other articles:

• Israeli, E, Grotto, I, Gilburd, B, Balicer, R D, Goldin, E, Wiik, A, Shoenfeld, Y (2005). Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54: 1232-1236 [Abstract] [Full Text]  
• Halfvarson, J, Standaert-Vitse, A, Jarnerot, G, Sendid, B, Jouault, T, Bodin, L, Duhamel, A, Colombel, J F, Tysk, C, Poulain, D (2005). Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut 54: 1237-1243 [Abstract] [Full Text]  
• Forcione, D G, Rosen, M J, Kisiel, J B, Sands, B E (2004). Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 53: 1117-1122 [Abstract] [Full Text]  
• Vermeire, S, Rutgeerts, P, Van Steen, K, Joossens, S, Claessens, G, Pierik, M, Peeters, M, Vlietinck, R (2004). Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. Gut 53: 980-986 [Abstract] [Full Text]  
• Hoffman, I E A, Demetter, P, Peeters, M, De Vos, M, Mielants, H, Veys, E M, De Keyser, F (2003). Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 62: 455-459 [Abstract] [Full Text]  
• Louis, E, Michel, V, Hugot, J P, Reenaers, C, Fontaine, F, Delforge, M, El Yafi, F, Colombel, J F, Belaiche, J (2003). Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52: 552-557 [Abstract] [Full Text]  
• Ibata-Ombetta, S., Jouault, T., Trinel, P.-A., Poulain, D. (2001). Role of extracellular signal-regulated protein kinase cascade in macrophage killing of Candida albicans. J. Leukoc. Biol. 70: 149-154 [Abstract] [Full Text]  
• POULAIN, D, SENDID, B, FAJARDY, I, DANZE, P., COLOMBEL, J., BRAUN, J, SUTTON, C., YANG, H., ROTTER, J (2000). Mother to child transmission of anti- S cerevisiae mannan antibodies (ASCA) in non-IBD families Reply. Gut 47: 870a-871 [Full Text]  
• Vasiliauskas, E A, Kam, L Y, Karp, L C, Gaiennie, J, Yang, H, Targan, S R (2000). Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 47: 487-496 [Abstract] [Full Text]  
• Fradin, C., Poulain, D., Jouault, T. (2000). beta -1,2-Linked Oligomannosides from Candida albicans Bind to a 32-Kilodalton Macrophage Membrane Protein Homologous to the Mammalian Lectin Galectin-3. Infect. Immun. 68: 4391-4398 [Abstract] [Full Text]  
• Sutton, C L, Yang, H, Li, Z, Rotter, J I, Targan, S R, Braun, J (2000). Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 46: 58-63 [Abstract] [Full Text]  
• Quinton, J-F, Sendid, B, Reumaux, D, Duthilleul, P, Cortot, A, Grandbastien, B, Charrier, G, Targan, S R, Colombel, J-F, Poulain, D (1998). Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42: 788-791 [Abstract] [Full Text]